Our scientists are advancing the development of immune-based therapies for cancer patients thanks to our donors and supporters. Learn more about their research and impact.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, 4th Floor | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
We introduce you to Rafael Amado, M.D., chief medical officer at Adaptimmune, a leader in T cell receptor (TCR) cancer immunotherapy.
On June 30, 2018, over 200 patients, caregivers, and advocates gathered to connect with experts and learn about the science of cancer immunotherapy in San Francisco.